The Ohio pharmacy board planned to ban the drug as a COVID-19 treatment until Gov. Mike DeWine spoke up about it.

The State of Ohio Board of Pharmacy has changed course on its ban of hydroxychloroquine and chloroquine as coronavirus treatments following the governor’s urging to do so.

Beginning Thursday, pharmacies, clinics and other medical institutions were to be prohibited from dispensing or selling the drugs to treat COVID-19, according to regulations issued by the State of Ohio Board of Pharmacy. They could still be used in clinical trials, said Cameron McNamee, director of policy and communications for the board.

That regulation change has since been pulled back by the board though. Instead, the board now plans to reexamine the issue with the assistance of the State Medical Board of Ohio, clinical experts and other stakeholders to determine its next steps, according to an announcement.

The board’s shift came after Gov. Mike DeWine asked the state pharmacy board on Thursday morning to rescind its plan to ban hydroxychloroquine and chloroquine as treatments for the virus.

DeWine said the decision of how to treat COVID-19 should instead be between patients and their doctors. The Ohio State Medical, the oldest and largest physician-led organization in Ohio, also said it supported a reversal of the ban.

“The Board of Pharmacy and the State Medical Board of Ohio should revisit the issue, listen to the best medical science and open the process up for comment and testimony from experts,” DeWine said in a prepared statement.

The FDA in mid-June revoked an emergency authorization for hydroxychloroquine that had allowed it to be used to treat COVID-19 patients. Despite the FDA’s revocation and until now, it could technically still be used for off-label treatment of the virus in Ohio, McNamee said.

“Basically, it’s a patient safety issue,” McNamee said on Wednesday before DeWine’s request and the board’s subsequent reversal. “We’re looking at the best science to determine what’s best for the patients of Ohio.”

Related: ‘HCQ saved my life after doctors denied treatment’ says corona survivor with high risk heart fluid

Two-Tiered Medicine: Why Is Hydroxychloroquine Being Censored and Politicized?

With a strong private initiative and rejecting the WHO’s measures, Guayaquil defeated COVID-19

Jane Orient, M.D. Commentary: To Stop the COVID-19 Surge, Let Physicians Practice Medicine

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »